COVID-19

Guillain-Barré syndrome and COVID-19 in Italy 1:41
Guillain-Barré syndrome and COVID-19 in Italy
Sabrina Ravaglia • 29 Apr 2020
Impact of COVID-19 on neurological disorders 1:32
Impact of COVID-19 on neurological disorders
Elena Moro • 22 Sep 2020
COVID-19 neurological manifestations: short and long-term 3:24
COVID-19 neurological manifestations: short and long-term
Elena Moro • 22 Sep 2020
Education on remote patient care in response to the COVID-19 pandemic 1:18
Education on remote patient care in response to the COVID-19 pandemic
Cristian Falup-Pecurariu • 22 Sep 2020
Challenges and good outcomes with telemedicine during COVID-19 2:27
Challenges and good outcomes with telemedicine during COVID-19
Alfonso Fasano • 16 Sep 2020
The challenge of diagnosing heterogeneous movement disorders 2:16
The challenge of diagnosing heterogeneous movement disorders
Cynthia Comella • 17 Sep 2020
The importance of longitudinal COVID-19 studies and the potential of ASOs 2:30
The importance of longitudinal COVID-19 studies and the potential of ASOs
Tiago Outeiro • 18 Sep 2020
Complications with Parkinson’s disease and COVID-19 3:05
Complications with Parkinson’s disease and COVID-19
Alfonso Fasano • 16 Sep 2020
The outcome of COVID-19 in Parkinson’s patients 1:44
The outcome of COVID-19 in Parkinson’s patients
Alfonso Fasano • 16 Sep 2020
How COVID-19 affects patients with movement disorders 1:03
How COVID-19 affects patients with movement disorders
Esther Cubo • 10 Sep 2020
The impact of COVID-19 on clinical care for movement disorders 1:34
The impact of COVID-19 on clinical care for movement disorders
Esther Cubo • 10 Sep 2020
Feasibility of telecommunications for movement disorders during COVID-19 3:18
Feasibility of telecommunications for movement disorders during COVID-19
Esther Cubo • 10 Sep 2020
Remote management and telecommunications for movement disorders during COVID-19 5:33
Remote management and telecommunications for movement disorders during COVID-19
Esther Cubo • 10 Sep 2020
How treatment of Parkinson’s disease is affected by telematic consultations 1:27
How treatment of Parkinson’s disease is affected by telematic consultations
Patricia Maria Carvalho Aguiar • 7 Sep 2020
The impact of stress from the COVID-19 pandemic on the brain 4:28
The impact of stress from the COVID-19 pandemic on the brain
Andreas Meyer-Lindenberg • 20 Jul 2020
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
The content of VJNeurology is intended for healthcare professionals